http://www.medpagetoday.com
Evan A. Stein, M.D., Ph.D., Metabolic and Atherosclerosis Research Center in Cincinnati
Allen J. Taylor, M.D., of the Uniformed Services University of the Health Sciences Walter Reed Army Medical Center in Washington
Controversy over the ENHANCE trial continued despite lengthy presentations at the American College of Cardiology meeting earlier this month. In this exclusive video report MedPage Today talks in-depth with two researchers about ezetimibe, LDL, and clinical implications of the trial.
This series is the most informative and balanced report that I have seen on this subject. Everyone who has an interest in this subject, should take the time to view all three of these rports. I think that the last comment that more people could die in the next two years than all the people who died in Iraq if Vytorin is taken off the shelves, is striking and graphically illustrates the point.
Gene Costa
genecosta2 3 years ago